Alzai Health Corp. has seen a notable increase in its stock price this week, following its recent developments in the healthcare technology sector.
Alzai Health Corp. (ALZI.V) has experienced a 10% rise this week, closing at C$0.39. The company's recent activities, particularly in AI-driven Alzheimer's risk screening, have garnered attention in the market. Here's a closer look at what's been happening with Alzai Health Corp. this week.
Investor takeaway: Investors should consider the implications of Alzai Health Corp.'s recent IPO and strategic agreements, as well as the company's current trading patterns and technical indicators.
Advertisement
Alzai Health Corp.
ALZI.V
ALZI.V
Alzai Health Corp.
WealthAwesomeMarket cap
$23.97M
52W high
$0.50
52W low
$0.28
1W change
+17.46%
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on ALZI's historical volatility
30-Day Vol
113.5%
Annualized
90-Day Vol
111.6%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.31
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.35 | C$0.24 – C$0.52 |
| 60 trading days | C$0.33 | C$0.19 – C$0.57 |
| 90 trading days | C$0.31 | C$0.16 – C$0.61 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Alzai Health Corp. Stock Rises 10% This Week
Despite the weekly gain, the stock remains down 8.33% over the past month, highlighting volatility since its IPO.
Bull case
The successful completion of Alzai Health's IPO and the validation of its AI-driven risk screening could position the company well in a growing market. The strategic agreement to expand its offerings in the U.S. adds to its potential for growth.
Bear case
Currently, the stock is trading below its moving averages, which could indicate challenges ahead. Additionally, the low trading volume compared to its average may suggest that investor interest is waning.
Recent Price Action
Advertisement
Alzai Health Corp. has closed at C$0.39, reflecting a 10% increase over the past week. Despite this positive weekly performance, the stock has seen a decline of 8.33% over the last month and is down 2.22% year-to-date.
Catalysts and Company News
This week, Alzai Health Corp. has been in the spotlight due to its completion of an initial public offering, which raised $4.05 million. Additionally, the company announced the validation of its AI-driven Alzheimer's risk identification models, showing promising results that could enhance its market presence. Moreover, a strategic agreement with Centauri Health Solutions aims to expand its offerings in the U.S. market.
Technical Picture
The technical indicators for Alzai Health Corp. show that the stock is currently trading at C$0.39, which is 14.7% below both its 50-day and 200-day moving averages of C$0.46. The stock's 52-week range is between C$0.39 and C$0.50, indicating it is currently at the lower end of its trading range. Notably, the latest volume of 5,008 shares is significantly lower than the 20-day average volume of 24,519 shares, suggesting reduced trading activity.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
